Bottom line
SUHAX vs JDOC: the short answer
SUHAX (DWS Health and Wellness Fund) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.
JDOC is cheaper at 0.65% vs 1.34% — a difference of $69 a year per $10,000 invested.
SUHAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
SUHAX vs JDOC side by side
| SUHAX | JDOC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | DWS (Xtrackers) | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.34% | 0.65% |
| Annual cost per $10k | $134 | $65 |
| 10-yr cost on $10k (prospectus) | $2,095 | $810 |
| Max front load | 5.75% | None |
| 12b-1 fee | 0.24% | — |
| 1-yr return | — | +14.9% |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +17.1% | +11.3% |
| Worst quarter | −12.1% | −11.9% |
| Net assets (fund) | $231.8M | $9.1M |
| Number of holdings | 65 | 61 |
| Portfolio turnover | 2% | 92% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SUHAX | JDOC | Difference |
|---|---|---|---|
| 2025 | +12.3% | +14.9% | −2.7% |
| 2024 | +3.3% | −0.6% | +4.0% |
Source: Fund prospectus bar charts
Holdings overlap
16 of SUHAX's top 25 holdings also appear in JDOC's top 25.
| Holding | SUHAX | JDOC |
|---|---|---|
| Eli Lilly & Co | 13.85% | 7.76% |
| Johnson & Johnson | 6.19% | 4.82% |
| UnitedHealth Group Inc | 5.73% | 5.85% |
| AbbVie Inc | 4.90% | 7.85% |
| Merck & Co Inc | 4.85% | 4.82% |
| AstraZeneca PLC | 3.80% | 3.76% |
| Thermo Fisher Scientific Inc | 3.46% | 3.73% |
| Intuitive Surgical Inc | 2.69% | 1.93% |
| Stryker Corp | 2.61% | 2.23% |
| Abbott Laboratories | 2.39% | 3.11% |
| Danaher Corp | 2.13% | 2.16% |
| Bristol-Myers Squibb Co | 1.50% | 3.57% |
| Regeneron Pharmaceuticals Inc | 1.43% | 1.60% |
| Cardinal Health Inc | 1.34% | 1.51% |
| Cencora Inc | 1.26% | 2.07% |
Source: SEC Form N-PORT
SUHAX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between SUHAX and JDOC?
Which is cheaper, SUHAX or JDOC?
Should I own both SUHAX and JDOC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.